INS and Insulin resistance: In terms of glucose metabolism phenotypes, compared with those in the BCN-F group, fasting serum glucose (p < 0.01, Fig. 4n) levels, fasting serum insulin (p < 0.001, Fig. 4o) levels, and homeostasis model assessment — insulin resistance (HOMA-IR, p < 0.001, Supplementary Fig. S8b) levels increased.